Free Trial

NeurAxis Q3 2023 Earnings Report

NeurAxis logo
$2.40 0.00 (0.00%)
(As of 12/20/2024 04:33 PM ET)

NeurAxis EPS Results

Actual EPS
-$1.06
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

NeurAxis Revenue Results

Actual Revenue
$0.48 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

NeurAxis Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment (Ad)

This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.

Click here for the ticker >>>

NeurAxis Earnings Headlines

Neuraxis files $25M mixed securities shelf
2025 could be “worse than the dot-com bust”, says man who predicted 2008 banking crisis
Dan is sharing his latest work with the public. Because what he's tracking right now, he says, is too serious to keep private.
Neuraxis files to sell 6.57M shares of common stock for holders
See More NeurAxis Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like NeurAxis? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NeurAxis and other key companies, straight to your email.

About NeurAxis

NeurAxis (NASDAQ:NRXS), a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.

View NeurAxis Profile

More Earnings Resources from MarketBeat

Upcoming Earnings